Outgoing Novartis CEO Hunts for His Next Big Challenge Post author:Sam Post published:January 24, 2018 Post category:BioPharma Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis. Source: BioSpace You Might Also Like MyoKardia Sees Positive Results in Mid-Stage Heart Trial March 8, 2018 OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe… February 18, 2018 Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to … November 21, 2017
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçe… February 18, 2018
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to … November 21, 2017